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Abstract 
Acute hypoxia results in uncontrolled release of glutamate and the 
consequent stimulation of N-methyl-D-aspartate (NMDA) receptors, which 
affects the whole ionic homeostasis and finally activates apoptosis of 
neurons. A potential therapeutic approach to prevent this sequence of events 
is a blockade of NMDA receptors. Meanwhile, in different models of acute 
hypoxia, activation of delta-opioid receptors demonstrates significant cardio- 
and neuroprotective effects with a consequent increase in animal survival. 
Thus, we aimed to test the effects of Morphine or Ketamine on 
hemodynamics, acid-base status and early survival in rats after asphyxia 
cardiac arrest (ACA). 
Methods: After instrumentation under anesthesia with Thiopental sodium 
(60 mg/kg, i.p.), Wistar rats (n=21) weighing between 350–400 g were 
randomly assigned to three groups where: 1. Morphine 5 mg/kg iv (n=7) was 
given 10 min before ACA; 2. Ketamine 40 mg/kg iv (n=7) was given 10 min 
before ACA; 3. Control (n=7), the same amount of NaCl 0,9% iv was given 
10 min before ACA. The rats were asphyxiated by corking the tracheostomia 
tube at the end of expiration for 5 min. Resuscitation was initiated by an 
injection of epinephrine (0.02 mg/kg, iv), followed by manual thoracic 
compressions (180 compressions/min) and mechanical ventilation (21% O2, 
80 breaths/min). Invasive mean arterial pressure (MAP) was recorded at the 
baseline (BL), injections (Inj), every 1 min during ACA (As) and every 5 min 
in post-resuscitation (PR) period. Blood gas samples were taken at the BL 
and 10 min at the PR period. Early survival was determined at the 20 min 
after ACA. 
Results: No differences in MAP between the rats was found at the BL period. 
On the one hand, iv injection of Ketamine significantly reduced MAP before 
ACA when compared to the Morphine and Control groups. On the other 
hand, the rats pre-treated with Ketamine got significantly higher MAP during 
PR period (Fig.1) and had significantly lower production of lactate (Fig.3) 
when compared to the rats treated with Morphine or only NaCl 0,9%. Six of 
the seven rats survived at the 20 min after ACA in the Ketamine group while 
four of the seven and two of the seven rats survived in the Morphine and 
Control groups respectively (P=0,122) (Fig. 4). 
Conclusion: Pre-treatment with Ketamine attenuated significantly 
disturbances in hemodynamics and acid-base status after ACA, but it did not 
improve significantly early survival when compared to the rats pre-treated by 
Morphine or only NaCl 0,9%. 
Introduction 
Experimental studies demonstrate that opioids can preserve cellular status 
during acute hypoxia in many organs and tissues including: intestine [1], 
skeletal muscle [2], myocardium [3,4] and brain [5,6]. In acute hypoxia 
conditions, Morphine has shown significant neuroprotective effect with a 
consequent increase in mice and rat survival [7,8]. Meanwhile, it has been also 
found that high doses of Morphine might inhibit NMDA receptors [9]. Today it 
is well known that inhibiting of NMDA receptor by Ketamine reduces neuronal 
apoptosis, attenuates the systemic inflammatory response to tissue injury, and 
also maintains cerebral perfusion pressure as a result of sympathetic nervous 
system activation [10-13]. However, to our knowledge nobody has tested the 
effects of Morphine or Ketamine in rats with acute hypoxia due to cardiac 
arrest. 
Aims 
To study effects of pre-treatment with Morphine or Ketamine on 
hemodynamics, acid-base status, plasma levels of neuron specific enolase 
(NSE) and s100 calcium binding protein B  and early survival in rats after 
asphyxia cardiac arrest. 
Methods and Materials 
Ethics: the experimental study with rats was approved by the Animal Care 
and Use Committee of the Astana Medical University, Astana, Kazakhstan.  
Animal Instrumentation: under anesthesia with Thiopental sodium (60 mg/
kg, i.p.), each rat was inserted stainless-steel tracheal tube in trachea. The rats 
were mechanically ventilated with room air and a tidal volume of 8 ml/kg 
using small animal ventilator (TOPO Dual mode ventilator, Kent Scientific 
Corp., USA). A 24G central venous catheter (Arrow) was inserted into the 
right femoral vein for drug administration and taking of blood sampling. A 
22G catheter (22G venflon, BD, Sweden) was inserted into the right femoral 
artery for continuous blood pressure monitoring. 
Average time for the instrumentation was about 10 min and all instrumentations in the study 
were performed by one experienced person.   
Methods and Materials (cont.) 
After instrumentation and following 10 min pause, all animals were randomly 
assigned into 3 groups: 1. Morphine group (n=7), where the rats were  given iv 
Morphine 5 mg/kg 10 min before cardiac arrest 2. Ketamine group (n=7), 
where the rats were given iv Ketamine 40 mg/kg 10 min before cardiac arrest, 
3. Control group (n=7), where the rats were given an equal quantity of NaCl 
0,9% 10 min before cardiac arrest.  
Induction of cardiac arrest (CA):  CA was induced by corking of tracheal tube 
for 5 min and defined as a mean arterial pressure (MAP) bellow 20 mm Hg. 
Resuscitation was initiated by an injection of epinephrine (0.02 mg/kg, iv) and 
followed by mechanical ventilation (21% O2, 80 breaths/min) and manual 
thoracic compressions (180 compressions/min). Restoration of spontaneous 
circulation (ROSC) was defined as a return of MAP above 60 mmHg. 
Ventilation was maintained until spontaneous breathing began. The 
temperature was kept at 36,5 °C to 37,5 °C by a heating pad during the study. 
Arterial blood samples were taken at the baseline and at 10 min after the start 
of resuscitation. MAP was recorded at the baseline, after iv injection of the 
study drugs or saline, at 1,2,3,4,5 min after induction of CA and at 
1,5,10,15,20 min in post-resuscitation period.  Levels of neuron specific 
enolase (NSE) and s100 calcium binding protein B were measured 
photometrically in rat plasma using ELISA kit (MyBioSource Inc., San Diego, 
CA, USA). All survived rats were terminated by huge doses of Thiopental 
sodium at the end of  study. 
Statistical analysis:  Statistical analyses were performed using SPSS software, 
version 21.0 (SPSS, Inc., Chicago, IL, USA). Data was assessed by two-factor 
analysis of variance for repeated measurements. If the F value was statistically 
significant, Scheffé’s test was used for post hoc intergroup analysis. P<0.05 
was considered to indicate a statistically significant difference.   
Results 
Pre-treatment of rats with Ketamine resulted in significantly better 
hemodynamic stability after asphyxial cardiac arrest as compared with two 
other study groups (Fig. 1). The rats in Ketamine group demonstrated 
significantly low accumulation of both lactate and hydrogen ions in blood as 
compared to the rats in Control group (Fig. 2 and 3). As we did not apply 
oxygen in our experiments, a very high mortality in the Control group was 
observed (Fig. 4). However, some trends for increasing of survival in both  
Ketamine and Morphine groups  was also observed (Fig. 4). Finally, we did 
not find any differences in plasma concentration of NSE and s100 calcium 
binding protein B between the study groups (data not shown).                
Figures 
Figure 1. Changes of mean arterial pressure (MAP) in the study 
groups at baseline (BL), after iv injection (Inj) of the study drugs or 
saline, at 1,2,3,4,5 min after induction of asphyxia (As) and at 
1,5,10,15,20 min in post-resuscitation (PR) period. *P<0.05 between 
Ketamine and Control groups. §P<0.05 between Ketamine and  
Morphine groups   
Figure 2. Comparison of pH levels measured at baseline and 
at 10 min in in post-resuscitation period between the study 
groups. *P<0.05 between Ketamine and Control groups.   
Figure 3. Comparison of Lactate levels measured at baseline and at 
10 min in in post-resuscitation period between the study groups. 
*P<0.05 between Ketamine and Control groups.  
Figure 4. 20-min survival in the Ketamine, Morphine and 
Control study groups. 
Comments and Conclusions 
In terms of mortality, our experimental model of asphyxial caridac arrest in 
rats without application of oxygen mimics closely cardiac arrest situation in 
humans. After 5 min period of anoxia condition, most of the rats in Control 
group died during the first 20 min after cardiac arrest. In turn of, trend for 
increased survival was found in both Ketamine and Morphine groups. 
Influence of Ketamine on hemodynamic status in our study is very consistent 
with findings from previous experimental and clinical research works. 
Further investigations are needed to elucidate whether Ketamine or Morphine 
play any role in prevention of neuronal injury in experimental animals and 
humans after cardiac arrest.   
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